Overview of benign and malignant lacrimal gland tumors.
Gündüz AK, Yeşiltaş YS, Shields CL.
Curr Opin Ophthalmol. 2018 Sep;29(5):458-468. doi: 10.1097/ICU.0000000000000515.
Case Series of Laser Therapy of Eyelid Peripunctal Benign Tumor.
Song N, Tong H, Ma J, Zhang J.
Photobiomodul Photomed Laser Surg. 2021 Oct;39(10):661-664. doi: 10.1089/photob.2021.0007. Epub 2021 Oct 1.
Modified argon laser therapy for benign tumor of the eyelid.
Han J, Lee SH, Choi CY, Khoramnia R, Kim J, Shin HJ.
BMC Ophthalmol. 2022 Sep 24;22(1):383. doi: 10.1186/s12886-022-02601-w.
Tumors, tumor therapies, autoimmunity and the eye.
Wildner G.
Autoimmun Rev. 2021 Sep;20(9):102892. doi: 10.1016/j.autrev.2021.102892. Epub 2021 Jul 3.
Judah Folkman.
Adamis AP, Miller JW.
Semin Ophthalmol. 2009 May-Jun;24(3):128-9. doi: 10.1080/08820530902800116.
Benign Lobular Inner Nuclear Layer Proliferations of the Retina Associated with Congenital Hypertrophy of the Retinal Pigment Epithelium.
Sanfilippo CJ, Javaheri M, Handler S, Berry JL, Cobrinik D, Deardorff MA, Sun M, Schmidt RJ, Barkmeier AJ, Nagiel A.
Ophthalmology. 2023 Mar;130(3):265-273. doi: 10.1016/j.ophtha.2022.10.011. Epub 2022 Oct 18.
Iris melanocytoma.
Radovanović AB, Krnjaja BD, Jaksić V.
Srp Arh Celok Lek. 2016 Jan-Feb;144(1-2):74-6. doi: 10.2298/sarh1602074b.
Metastatic tumours to the eye. Review of metastasis to the iris, ciliary body, choroid, retina, optic disc, vitreous, and/or lens capsule.
Shields CL, Kalafatis NE, Gad M, Sen M, Laiton A, Silva AMV, Agrawal K, Lally SE, Shields JA.
Eye (Lond). 2023 Apr;37(5):809-814. doi: 10.1038/s41433-022-02015-4. Epub 2022 Mar 19.
Posterior segment manifestations of ocular metastasis.
Kongwattananon W, Pothikamjorn T, Somkijrungroj T.
Curr Opin Ophthalmol. 2023 Nov 1;34(6):522-528. doi: 10.1097/ICU.0000000000000988. Epub 2023 Aug 9.
Conjunctival and Corneal Fibrous Histiocytoma: Brief review.
Singh T, Ichhpujani P.
Semin Ophthalmol. 2021 Oct 3;36(7):569-572. doi: 10.1080/08820538.2021.1900286. Epub 2021 Mar 25.
